GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Notes Receivable

Labiana Health (XMAD:LAB) Notes Receivable : €0.00 Mil (As of Dec. 2022)


View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Notes Receivable?

Labiana Health's Notes Receivable for the quarter that ended in Dec. 2022 was €0.00 Mil.


Labiana Health Notes Receivable Historical Data

The historical data trend for Labiana Health's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Notes Receivable Chart

Labiana Health Annual Data
Trend Dec20 Dec21 Dec22
Notes Receivable
- - -

Labiana Health Semi-Annual Data
Dec20 Dec21 Jun22 Dec22
Notes Receivable - - - -

Labiana Health Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Labiana Health Notes Receivable Related Terms

Thank you for viewing the detailed overview of Labiana Health's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Labiana Health (XMAD:LAB) Business Description

Traded in Other Exchanges
N/A
Address
Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.